Gelteq Ltd (GELS)

$3.00 +0.06 (2.04%)
Market Cap N/A
Revenue (ttm) 79,843.00
Net Income (ttm) -3.51M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin -2,283.44%
Debt to Equity Ratio 0.07
Volume 7,509
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts Strong Buy
Price Target N/A

Latest News on GELS

Gelteq Receives FDA Approval of its Suitability Petition for New Animal Drug

Dec 17, 2024, 8:30 AM EST - 4 weeks ago

Gelteq Receives FDA Approval of its Suitability Petition for New Animal Drug

Gelteq to Participate in the Benchmark Company 13th Annual Discovery Investor Conference

Dec 9, 2024, 8:30 AM EST - 5 weeks ago

Gelteq to Participate in the Benchmark Company 13th Annual Discovery Investor Conference

Gelteq Announces Largest U.S. Customer Increases Initial Order by 50% to Meet Growing Market Demand

Dec 2, 2024, 8:30 AM EST - 6 weeks ago

Gelteq Announces Largest U.S. Customer Increases Initial Order by 50% to Meet Growing Market Demand

Gelteq Announces 400,000 Units Enter into Production in November 2024

Nov 26, 2024, 8:30 AM EST - 7 weeks ago

Gelteq Announces 400,000 Units Enter into Production in November 2024

Gelteq Expands Operations in United States with Appointment of Adam Bendell as President of U.S. Operations to Scale Domestic Business

Nov 12, 2024, 9:00 AM EST - 2 months ago

Gelteq Expands Operations in United States with Appointment of Adam Bendell as President of U.S. Operations to Scale Domestic Business

Gelteq Limited Closes US$5.2 Million Initial Public Offering

Oct 30, 2024, 10:00 AM EDT - 2 months ago

Gelteq Limited Closes US$5.2 Million Initial Public Offering

Gelteq Limited Prices US$5.2 Million Initial Public Offering

Oct 28, 2024, 9:50 PM EDT - 2 months ago

Gelteq Limited Prices US$5.2 Million Initial Public Offering